PeptideDB

(Z)-4-Amino-4-oxobut-2-enoic acid 557-24-4

(Z)-4-Amino-4-oxobut-2-enoic acid 557-24-4

CAS No.: 557-24-4

(Z)-4-Amino-4-oxobut-2-enoic acid is an endogenously produced metabolite.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

(Z)-4-Amino-4-oxobut-2-enoic acid is an endogenously produced metabolite.

Physicochemical Properties


Molecular Formula C4H5NO3
Molecular Weight 115.09
Exact Mass 115.027
CAS # 557-24-4
PubChem CID 5280451
Appearance White to off-white solid powder
Density 1.376g/cm3
Boiling Point 408.6ºC at 760mmHg
Melting Point 158-161 °C(lit.)
Flash Point 200.9ºC
Index of Refraction 1.528
LogP -1
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 3
Rotatable Bond Count 2
Heavy Atom Count 8
Complexity 138
Defined Atom Stereocenter Count 0
SMILES

C(=C\C(=O)O)\C(=O)N

InChi Key FSQQTNAZHBEJLS-UPHRSURJSA-N
InChi Code

InChI=1S/C4H5NO3/c5-3(6)1-2-4(7)8/h1-2H,(H2,5,6)(H,7,8)/b2-1-
Chemical Name

(Z)-4-amino-4-oxobut-2-enoic acid
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Additional Infomation Maleamic acid is a dicarboxylic acid monoamide of maleamic acid. It has a role as an Escherichia coli metabolite and a bacterial xenobiotic metabolite. It is a dicarboxylic acid monoamide and an alpha,beta-unsaturated monocarboxylic acid. It is functionally related to a maleic acid. It is a conjugate acid of a maleamate.
Maleamic acid has been reported in Pogostemon cablin and Trypanosoma brucei with data available.

Solubility Data


Solubility (In Vitro) DMSO :~100 mg/mL (~868.89 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.08 mg/mL (18.07 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.08 mg/mL (18.07 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.08 mg/mL (18.07 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 8.6889 mL 43.4443 mL 86.8885 mL
5 mM 1.7378 mL 8.6889 mL 17.3777 mL
10 mM 0.8689 mL 4.3444 mL 8.6889 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.